Skip to main content

Table 5 Comparison of domain scores for Female Sexual Quotient (QS-F) questionnaire in the different stages of the study for the 4 types of LARCs evaluated

From: Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study

Parameter

LNG

ENG

CuID

SIUD

P value1

P value2

Desire

   

0.002

0.334

 Stage 1

21.3 ± 4

(22)

20.6 ± 5.2

(20)

21.3 ± 3.8

(22)

19.7 ± 8.1

(22)

  

 Stage 2

22.4 ± 4.1*

(22)

16.5 ± 6.5*†£

(16)

23.2 ± 3.4†

(23)

23.1 ± 4.6£

(24)

  

Preliminary

  

0.001

0.053

 Stage 1

9.6 ± 0.8

(10)

9.2 ± 1.2

(10)

9.2 ± 1.6

(10)

9 ± 1.5

(10)

  

 Stage 2

9.1 ± 1.4*

(10)

7.3 ± 2.6*†£

(6)

9.4 ± 0.9†

(10)

9.1 ± 1.3£

(10)

  

Arousal

   

 < 0.001

0.534

 Stage 1

17.1 ± 2.5

(18)

15.4 ± 3.8

(16)

18 ± 2.3

(18)

16 ± 4.2

(18)

  

 Stage 2

17.1 ± 2.4 *

(16)

12.1 ± 4.8*†£

(14)

18.1 ± 2.6†

(19)

17.2 ± 2.9£

(18)

  

Comfort

   

0.045

0.069

 Stage 1

15.9 ± 2.9

(16)

15.8 ± 3.4

(18)

16.6 ± 3.4

(17)

14.2 ± 4.7

(16)

  

 Stage 2

16.8 ± 3.1

(18)

14.4 ± 4.8†

(16)

18.2 ± 1.7†

(18)

16.8 ± 3.5

(18)

  

Orgasm & Satisfaction

   

 < 0.001

0.471

 Stage 1

16.5 ± 4.4 (18)

14.5 ± 3.8

(16)

15.4 ± 3.5 (16)

14 ± 4.4 (14)

  

 Stage 2

16.4 ± 4.2*

(18)

10.6 ± 4.7*†£

(10)

16.1 ± 2.8†

(16)

14.9 ± 3.9£

(16)

  

Total score

   

 < 0.001

0.791

 Stage 1

80.4 ± 11.5

(84)

75.4 ± 14

(78)

80.6 ± 9.8

(81)

73 ± 18.4

(74)

  

 Stage 2

81.8 ± 11.5*

(82)

60.8 ± 21.1*†£

(66)

85.1 ± 8.2†

(88)

81.1 ± 13.2£

(84)

  
  1. LNG levonorgestrel intrauterine system, ENG etonogestrel-releasing implant, CuIUD copper intrauterine device, SIUD silver intrauterine device. P value 1refers to comparison between the LARC types and p value 2refers to comparison between stages. Symbols *,†,£indicates pairs with significative differences in post-hoc test. Data presented as mean ± SD (median)